Phase Ib/II Study of Pembrolizumab with Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (PLANET)

Clinical Trial Grant

Duke Scholars

Principal Investigator Michael Aaron Morse Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Merck

Start Date

April 29, 2017

End Date

March 31, 2022

Administered By

Duke Cancer Institute

Awarded By

Merck

Start Date

April 29, 2017

End Date

March 31, 2022